본문으로 바로가기

의료진 소개

신정현 의사

신정현 교수

비뇨의학과 관심의료진 등록

전문 진료 분야

여성 비뇨기 질환, 여성 배뇨 장애, 신경인성 방광

진료 일정

학력사항

  • 울산대학교 의과대학 박사
  • 울산대학교 의과대학 석사
  • 울산대학교 의과대학 졸업

교육 및 연구경력

  • 2026-현재  | 이대목동병원 비뇨의학과 임상부교수
  • 2022-2025  | 이대목동병원 비뇨의학과 임상조교수
  • 2021  | 서울아산병원 비뇨의학과 촉탁임상전임강사
  • 2018-2021  | 서울아산병원 비뇨의학과 임상강사
  • 2014-2018  | 서울아산병원 비뇨의학과 전공의
  • 2013-2014  | 서울아산병원 인턴

수상경력

  • 2022 | 대한비뇨의학회 학술상 (국외논문 '임상' 우수상)
  • 2023 | 대한배뇨장애요실금학회 학술상
  • 2022 | Annual Meeting of KUA - 대한비뇨의학회 우수연제 발표상
  • 2021 | 대한비뇨의학회 우수 초록 발표상
  • 2021 | 서울아산병원 학술, 연구 표창장
  • 2020 | International Continence Society Best Presentation Award
  • 2020 | 대한배뇨장애요실금학회 젊은 연구자 연구비 지원사업 최우수상
  • 2020 | 대한비뇨의학회 학술상 (국외논문 '임상' 우수상)
  • 2020 | 서울아산병원 외과계 임상강사 최우수 논문실적 표창장
  • 2019 | 서울아산병원 학술, 연구 표창장
  • 2018 | 대한배뇨장애요실금학회 송정 젊은연구자상
  • 2016 | 대한비뇨기과학회 전공의 수련 중 평가시험 우수상 (3년차 1등)
  • 2015 | 서울아산병원 2014년도 하반기 의무기록 작성 최우수 전공의
  • 2014 | 서울아산병원 2014년도 상반기 의무기록 작성 최우수 전공의

기타 학술 관련 경력

  • 2023-현재  | 대한비뇨의학회 21대 여성정책위원회 위원
  • 2023-현재  | 대한배뇨장애요실금학회 기획위원
  • 2023-현재  | 대한배뇨장애요실금학회 실무자위원회 위원
  • 2023-현재  | 대한비뇨내시경로봇학회 연구위원
  • 2023-현재  | 대한여성성건강연구학회 부총무
  • 대한비뇨기종양학회 회원

논문

  •  The usefullness and ergonomics of a new robotic system for flexible ureteroscopy and laser lithotripsy for treating renal stones.  Investigative and Clinical Urology. 2022-11. 
  •  Safety of human embryonic stem cell-derived mesenchymal stem cells for treating interstitial cystitis: A phase 1 study.  Stem Cells Translational Medicine. 2022-10. 
  •  Diagnosis and treatment of urinary incontinence in female patients.  Korean Journal of Family Practice. 2022-09. 
  •  Effects of different types of hysterectomies on postoperative urodynamics and lower urinary tract symptoms.  Investigative and Clinical Urology. 2022-02. 
  •  Intravital imaging and single cell transcriptomic analysis for engraftment of mesenchymal stem cells in an animal model of interstitial cystitis/bladder pain syndrome.  Biomaterials. 2022-01. 
  •  A Preclinical Study of Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells for Treating Detrusor Underactivity by Chronic Bladder Ischemia.  Stem cell reviews and reports. 2021-12. 
  •  Features of various bladder lesions and their impact on clinical symptoms and recurrence in interstitial cystitis.  Journal of Urology. 2021-09. 
  •  Therapeutic efficacy of human embryonic stem cell-derived multipotent stem/stromal cells in diabetic detrusor underactivity: A preclinical study.  Journal of Clinical Medicine. 2020-09. 
  •  Treatment outcomes and overactive bladder symptoms after midurethral sling in female patients with or without various neurological diseases.  Neurourology and Urodynamics. 2020-09. 
  •  Synergistic effects of N-acetylcysteine and mesenchymal stem cell in a lipopolysaccharide-induced interstitial cystitis rat model.  Cells. 2020-01. 
  •  Current and future directions of stem cell therapy for bladder dysfunction.  Stem cell reviews and reports. 2020-01. 
  •  Induction of detrusor underactivity by extensive vascular endothelial damages of iliac arteries in a rat model and its pathophysiology in the genetic levels.  Scientific reports. 2019-11. 
  •  De novo or resolved urgency and urgency urinary incontinence after midurethral sling operations: How can we properly counsel our patients?.  Investigative and Clinical Urology. 2019-09. 
  •  Urodynamic study for distinguishing multiple system atrophy from Parkinson disease.  Neurology. 2019-09. 
  •  Patterns and predictors of Hunner lesion recurrence in patients with interstitial cystitis.  Neurourology Urodynamics. 2019-06. 
  •  N-acetylcysteine prevents bladder tissue fibrosis in a lipopolysaccharide-induced cystitis rat model.  Scientific reports. 2019-05. 
  •  Effectiveness and persistence of mirabegron as a first-line treatment in patients with overactive bladder in real-life practice.  Lower Urinary Tract Symptoms. 2019-05. 
  •  Longitudinal intravital imaging of transplanted mesenchymal stem cells elucidates their functional integration and therapeutic potency in an animal model of interstitial cystitis/bladder pain syndrome.  Theranostics. 2018-11. 
  •  Comparison of efficacy between the single-dose and three-days prophylactic antibiotic regimen for the prevention of bacterial infections in patients with percutaneous nephrolithotomy: a randomized controlled study.  Urogenital Tract Infection. 2018-11. 
  •  In vitro, in vivo and clinical tests of a novel flexible ureteroscope for the diagnosis and treatment of kidney and ureteral diseases.  Investigative and Clinical Urology. 2018-09. 
  •  Long-term outcomes of endoscopic anti-reflux surgery in pediatric patients with vesicoureteral reflux: urinary tract infection, renal scarring and predictive factors for success.  Journal of Korean Medical Science. 2018-08. 
  •  Is it possible to prevent symptom recurrence after transurethral resection for Hunner lesion?.  International Neurourology Journal. 2018-06. 
  •  Downregulation of WNT11 is associated with bladder tissue fibrosis with interstitial cystitis/bladder pain syndrome without Hunner lesion.  Scientific reports. 2018-06. 
  •  The therapeutic effect of human embryonic stem cell-derived multipotent mesenchymal stem cells on chemical-induced cystitis in rats.  International Neurourology Journal. 2018-01. 
  •  Evaluation of the incidence and risk factors associated with persistent frequency in interstitial cystitis/bladder pain syndrome and efficacy of antimuscarinic treatment.  Investigative and Clinical Urology. 2017-09. 
  •  Additional low-dose antimuscarinics can improve overactive bladder symptoms in patients with suboptimal response to beta 3 agonist monotherapy.  Investigative and Clinical Urology. 2017-07. 
  •  Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.  Scientific reports. 2016-08.